SCHEMBL1126344

SCHEMBL1126344

CCN(CC)Cc1ccc(N)nc1.COc1cc(OC)c(Cl)c(-c2ccc(C(=O)Nc3ccc(CN(C)C)cn3)c3nccnc23)c1Cl

nearest known ligand 0.61

Predicted protein targets (top 1)

geneUniProtsupporting neighboursconfidence
FGFR3 P22607 20/20 0.61

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1126208 0.92 FGFR3 (0.69) FGFR3
SCHEMBL1126165 0.91 FGFR3 (0.71) FGFR3
SCHEMBL3312517 0.86 FGFR3 (0.49) FGFR3
SCHEMBL1126071 0.86 FGFR3 (0.71) FGFR3
SCHEMBL3313824 0.84 FGFR3 (0.57) FGFR3
SCHEMBL12678322 0.84 FGFR3 (0.83) FGFR3
SCHEMBL1126739 0.83 FGFR3 (0.82) FGFR3
SCHEMBL17023059 0.83 FGFR3 (0.54) FGFR3
SCHEMBL12678366 0.82 FGFR3 (0.70) FGFR3
SCHEMBL17023186 0.81 FGFR3 (0.57) FGFR3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2282995-A1 DERIVATIVES OF QUINOLINES AND QUINOXALINES AS PROTEIN TYROSINE KINASE INHIBITORS Novartis AG (CH) 2011-02-16 EP claimed